p53 pathway dysfunction in AML: beyond TP53 mutations

被引：5
|
作者：
Post, Sean M. [1 ]
Kornblau, Steven M. [1 ]
Quintas-Cardama, Alfonso [1 ]
机构：
[1] TCR2 Therapeut, Cambridge, MA 02142 USA
来源：
ONCOTARGET | 2017年 / 8卷 / 65期
关键词：
TP53; Mdm2; ACUTE MYELOID-LEUKEMIA; ACUTE LYMPHOBLASTIC-LEUKEMIA; ADULTS;
D O I：
10.18632/oncotarget.22713
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：108288 / 108289
页数：2
相关论文
共 50 条
  • [21] The relationship between TP53 mutations and overexpression of p53 and prognosis in malignant gliomas of childhood
    Pollack, IF
    Hamilton, RL
    Finkelstein, SD
    Campbell, JW
    Martinez, AJ
    Sherwin, RN
    Bozik, ME
    Gollin, SM
    CANCER RESEARCH, 1997, 57 (02) : 304 - 309
  • [22] TP53 MUTATIONS AND ABNORMAL P53 PROTEIN STAINING IN BREAST CARCINOMAS RELATED TO PROGNOSIS
    THORLACIUS, S
    THORGILSSON, B
    BJORNSSON, J
    TRYGGVADOTTIR, L
    BORRESEN, AL
    OGMUNDSDOTTIR, HM
    EYFJORD, JE
    EUROPEAN JOURNAL OF CANCER, 1995, 31A (11) : 1856 - 1861
  • [23] p53 Immunohistochemistry Patterns Are Surrogate Biomarkers for TP53 Mutations in Gastrointestinal Neuroendocrine Neoplasms
    Li, Junjie
    Wang, Jing
    Su, Dan
    Nie, Xiu
    Liu, Yueping
    Teng, Lianghong
    Pang, Junyi
    Wu, Huanwen
    Liang, Zhiyong
    GASTROENTEROLOGY RESEARCH AND PRACTICE, 2021, 2021
  • [24] Heterogeneity of TP53 Mutations and P53 Protein Residual Function in Cancer: Does It Matter?
    Monti, Paola
    Menichini, Paola
    Speciale, Andrea
    Cutrona, Giovanna
    Fais, Franco
    Taiana, Elisa
    Neri, Antonino
    Bomben, Riccardo
    Gentile, Massimo
    Gattei, Valter
    Ferrarini, Manlio
    Morabito, Fortunato
    Fronza, Gilberto
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [25] Is TP53 Mutated AML the Same Disease as TP53 Mutated MDS?
    Valk, Peter J. M.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S3 - S5
  • [26] TP53 mutations and relevance of expression of TP53 pathway genes in paediatric acute myeloid leukaemia
    Cucchi, David G. J.
    Bachas, Costa
    Klein, Kim
    Huttenhuis, Sander
    Zwaan, Christian M.
    Ossenkoppele, Gert J.
    Janssen, Jeroen M. W. M.
    Kaspers, Gertjan L.
    Cloos, Jacqueline
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 188 (05) : 736 - 739
  • [27] Isolated TP53 Mutations Portend Worse Prognosis in MDS and AML Compared to TP53 Mutations with Concurrent Myeloid-Associated Mutations
    Hussaini, Mohammad
    Abuel-Haija, Mohammad
    Padron, Eric
    David, Sallman
    Song, Jinming
    LABORATORY INVESTIGATION, 2018, 98 : 524 - 525
  • [28] Isolated TP53 Mutations Portend Worse Prognosis in MDS and AML Compared to TP53 Mutations with Concurrent Myeloid-Associated Mutations
    Hussaini, Mohammad
    Abuel-Haija, Mohammad
    Padron, Eric
    David, Sallman
    Song, Jinming
    MODERN PATHOLOGY, 2018, 31 : 524 - 525
  • [29] BSTNI/NCII POLYMORPHISM OF THE HUMAN P53 GENE (TP53)
    CHUMAKOV, PM
    JENKINS, JR
    NUCLEIC ACIDS RESEARCH, 1991, 19 (24) : 6969 - 6969
  • [30] Lack of p53 nuclear immunostaining is not indicative of absence of TP53 gene mutations in colorectal adenocarcinomas
    Colomer, A
    Erill, N
    Verdú, M
    Roman, R
    Vidal, A
    Cordon-Cardo, C
    Puig, X
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2003, 11 (02) : 130 - 137
12345